AndyPR
Senior Member
- Messages
- 2,516
The use of high-throughput technologies, also called “big-data” analysis or “omics” (for genomics, metabolomics, lipidomics, proteomics, etc.) is becoming increasingly useful for researchers across all disciplines of biomedicine. This approach enables comparative, large-scale analysis among conditions (for example disease vs. healthy states, or within subgroups of a disease). It also has other uses, ranging from biomarker discovery to ancestry identification to drug screening purposes to 23andMe genetic testing.
Although not credited on the page itself, I believe Dr. Zaher Nahle posts about big data in ME/CFS research.
http://solvecfs.org/big-data-an-important-tool-for-complex-diseases-like-mecfs/